ArticleFrontiers in immunology2025
Disease association study of Autoimmune and autoinflammatory diseases by integrating multi-modal data and hierarchical ontologies.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Autoimmune and autoinflammatory diseases (AIIDs) are characterized by significant heterogeneity and comorbidities, complicating their mechanisms and classification. Disease associations studies, or diseasome, facilitate the exploration of disease mechanisms and development of novel therapeutic strategies. However, the diseasome for AIIDs is still in its infancy. To address this gap, we developed a novel framework that utilizes multi-modal data and biomedical ontologies to explore AIID associations. Methods: We curated disease terms from Mondo/DO/MeSH/ICD, and three specialized AIID knowledge bases, creating an integrated repository of 484 autoimmune diseases (ADs), 110 autoinflammatory diseases (AIDs), and 284 associated diseases. By leveraging genetic, transcriptomic (bulk and single-cell), and phenotypic data, we built multi-layered AIID association networks and an integrated network supported by cross-scale evidence. Our ontology-aware disease similarity (OADS) strategy incorporates not only multi-modal data, but also continuous biomedical ontologies. Results: Network modularity analysis identified 10 robust disease communities and their representative phenotypes and dysfunctional pathways. Focusing on 10 highly concerning AIIDs, such as Behçet's disease and Systemic lupus erythematosus, we provide insights into the information flow from genetic susceptibilities to transcriptional dysregulation, alteration in immune microenvironment, and clinical phenotypes, and thus the mechanisms underlying comorbidity. For instance, in systemic sclerosis and psoriasis, dysregulated genes like CCL2 and CCR7 contribute to fibroblast activation and the infiltration of CD4+ T and NK cells through IL-17 signaling pathway, PPAR signaling pathway, leading to skin involvement and arthritis. Conclusion: These findings enhance our understanding of AIID pathogenesis, improving disease classification and supporting drug repurposing and targeted therapy development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.